SlideShare ist ein Scribd-Unternehmen logo
1 von 21
Downloaden Sie, um offline zu lesen
oclar.pptx
Ocular Drug Delivery
System
• The novel approach of drug delivery in which the drug is instilled on
the cul de sac cavity of the eye (space between eyelids and eyeballs)
is known as Ocular Drug Delivery System.
• INTRODUCTION
• Ocular administration of drug is primarily associated with the need to
treat ophthalmic diseases.
• Eye is the most easily accessible site for topical administration of a
medication.
• Ideal ophthalmic drug delivery must be able to sustain the drug
release and to remain in the vicinity of front of the eye for prolong
period of time.
The eye is a complex organ with unique anatomy and physiology.
The structure of the eye can be divided into two main parts:
the anterior segment and the posterior segment.
The anterior segment of the eye occupies approximately one-third while the
remaining portion is occupied by the posterior segment.
Tissues such as the cornea, conjunctiva, aqueous humor, iris, ciliary body, and lens
make up the anterior portion.
Back of the eye or posterior segment of the eye include; sclera, choroid, retinal
pigment epithelium, neural retina, optic nerve, and vitreous humor.
• The anterior and posterior segment of the eye is affected by
various vision-threatening diseases.
• glaucoma, allergic conjunctivitis, anterior uveitis, and cataract.
• Age-related macular degeneration (AMD) and diabetic
retinopathy
oclar.pptx
Nasolachrymal drainage system
Nasolachrymal drainage system consists of three parts;
the secretory system,
the distributive system and
the excretory system.
The secretory portion is composed of the lacrimal gland that
secreted tears are spread over the ocular surface by the eyelids
during blinking.
The secretory system is stimulated by blinking and temperature
change due to the tear evaporation and reflux secretors that have
an efferent parasympathetic nerve supply and secrete in response
to physical and emotional stimulation e.g. crying.
The distributive system consists of the eyelids and the tear
meniscus around the lid edges of the open eye, which spread tears
over the ocular surface by blinking, thus preventing dry areas from
developing.
The excretory part of the Nasolachrymal drainage system consists
of the lachrymal puncta, the superior, inferior and common
canaliculi; the lachrymal sac, and the nasochrymal duct.
In humans, the two puncta are the openings of the lachrymal
canaliculi and are situated on an elevated area known as the
lachrymal papilla.
It is thought that tears are largely absorbed by the mucous
membrane that lines the ducts andthe lachrymal sac; only a small
amount reaches the nasal passage
Tearfilm
The exposed part of the eye is covered by a thin fluid layer, the so-
called precorneal tear film.
The film thickness is reported to be about 3–10 Am depending on
the measurement method used.
The resident volume amounts to about 10μl.
The osmolality of the tear film equals 310–350 mOsm/kg in
normal eyes and is adjusted by the monovalent and divalent
inorganic ions such as Na+, K+, Cl-, HCO3-, and proteins.
The mean pH value of normal tears is about 7.4.
Advantages of Ocular Drug Delivery System
• 1. Increased accurate dosing. To overcome the side effects of pulsed
dosing produced by conventional systems.
2. To provide sustained and controlled drug delivery.
3. To increase the ocular bioavailability of drug by increasing the
corneal contact time. This can be achieved by effective adherence to
corneal surface.
4. To provide targeting within the ocular globe so as to prevent the
loss to other ocular tissues.
5. To circumvent the protective barriers like drainage, lacrimation and
conjunctival absorption.
Disadvantages of Ocular Drug Delivery System
• The residence time of the drug at the eye surface is less.
• Poor bioavailability.
• The instability of the dissolved drug.
• The low concentration of preservatives reduces shelf life after
opening the bottle.
Ideal Characteristics of Ocular Drug Delivery
System
• It should be sterile.
• It should be isotonic to body fluids.
• Buffer/pH adjustment.
• Less drainage tendency.
• Minimum protein binding.
• Mechanism of Ocular Drug Absorption
• Drugs administered by instillation must penetrate the eye and do so
primarily through the cornea followed by the non-corneal
routes.These non-corneal routes involve drug diffusion across the
conjunctiva and sclera and appear to be particularly important for
drugs that are poorly absorbed across the cornea
• Corneal permeation
• The permeation of drugs across the corneal membrane occurs from
the precorneal space. Transcellular transport occurs i.e. transport
between corneal epithelium and stroma.
• The productive absorption of most ophthalmic drugs results from
diffusional process across corneal membrane.
• Maximum absorption thus takes place through cornea, which leads
the drug into aqueous humor.
• Outer epithelium has only access to small ionic and lipophilic
molecules.
• Non-corneal permeation
• Primary mechanism of drug permeation is diffusion across sclera &
conjunctiva into intra ocular tissues.
• Although like cornea, the conjunctiva is composed of an epithelial
layer covering an underlying stroma, the conjunctival epithelium
offers substantially less resistance than does the corneal epithelium.
• This route is however, not productive as it restrains the entry of drug
into aqueous humor.
• This route is important for hydrophilic and large molecules, such as
insulin and p-aminoclonidine, which have poor corneal permeability.
Barriers to Ocular Drug Delivery System
• When a dosage form is either administered topically or systemically, it
faces multiple obstacles before it reaches its site of action.
• As a result, ocular bioavailability from topically administered drugs is
usually only 1%-7% of the applied dose.
Drug loss from the ocular surface
After instillation, the flow of lacrimal fluid removes instilled
compounds from the surface of eye. Even though the lacrimal
turnover rate is only about 1 µl/min the excess volume of the
instilled fluid is flown to the nasolacrimal duct rapidly in a
couple of minutes.
Another source of non-productive drug removal is its systemic
absorption instead of ocular absorption. Systemic absorption
may take place either directly from the conjunctival sac via
local blood capillaries or after the solution flow to the nasal
cavity.
• Lacrimal fluid-eye barriers
Corneal epithelium limits drug absorption from the lacrimal fluid into
the eye. The corneal epithelial cells form tight junctions that limit the
paracellular drug permeation.
• Therefore, lipophilic drugs have typically at least an order of
magnitude higher permeability in the cornea than the hydrophilic
drugs. In general, the conjunctiva is leakier epithelium than the
cornea and its surface area is also nearly 20 times greater than that of
the cornea
Blood-ocular barriers
The eye is protected from the xenobiotics in the blood stream by blood-ocular
barriers. These barriers have two parts: blood-aqueous barrier and blood-retina
barrier.
The anterior blood-eye barrier is composed of the endothelial cells in the uveam
(The middle layer of the eye beneath the sclera. It consists of the iris, ciliary body,
and choroid).
This barrier prevents the access of plasma albumin into the aqueous humor, and
also limits the access of hydrophilic drugs from plasma into the aqueous humor.
The posterior barrier between blood stream and eye is comprised of retinal
pigment epithelium (RPE) and the tight walls of retinal capillaries. Unlike retinal
capillaries the vasculature of the choroid has extensive blood flow and leaky walls.
Drugs easily gain access to the choroidal extravascular space, but thereafter
distribution into the retina is limited by the RPE and retinal endothelia.
oclar.pptx

Weitere ähnliche Inhalte

Ähnlich wie oclar.pptx

Barrier of drugs permeation through ocular route by Sushil Kumar Singh
Barrier of drugs permeation through ocular route by Sushil Kumar SinghBarrier of drugs permeation through ocular route by Sushil Kumar Singh
Barrier of drugs permeation through ocular route by Sushil Kumar SinghSushil Singh
 
Telithromycin ocular ointment
Telithromycin ocular ointmentTelithromycin ocular ointment
Telithromycin ocular ointmentrecentupdates
 
ODDS(Jeevitha.KB).pptx
ODDS(Jeevitha.KB).pptxODDS(Jeevitha.KB).pptx
ODDS(Jeevitha.KB).pptxSHREYAL7
 
Ssssssspofvv converted
Ssssssspofvv convertedSsssssspofvv converted
Ssssssspofvv convertedYa75sh
 
BARRIERS OF DRUG PERMEATION OF OCCULAR DRUG DELIVERY SYSTEM
BARRIERS OF DRUG PERMEATION OF OCCULAR DRUG DELIVERY SYSTEMBARRIERS OF DRUG PERMEATION OF OCCULAR DRUG DELIVERY SYSTEM
BARRIERS OF DRUG PERMEATION OF OCCULAR DRUG DELIVERY SYSTEMTanvi Mhashakhetri
 
Ophthalmic drugdelivery system
Ophthalmic drugdelivery systemOphthalmic drugdelivery system
Ophthalmic drugdelivery systemYamini Shah
 
Ocular Drug Delivery System
Ocular Drug Delivery SystemOcular Drug Delivery System
Ocular Drug Delivery SystemArunpandiyan59
 
Barriers and routes of occular drug delivery system
Barriers and routes of occular drug delivery systemBarriers and routes of occular drug delivery system
Barriers and routes of occular drug delivery systemShresthaPandey1
 
Occular Drug Delivery System
Occular Drug Delivery SystemOccular Drug Delivery System
Occular Drug Delivery SystemRUSHIKESHSHINDE80
 
Odds ocular drug delivery system
Odds ocular drug delivery system Odds ocular drug delivery system
Odds ocular drug delivery system akshay Bhama
 
OCULAR DRUG DELIEVERY SYSTEM
OCULAR DRUG DELIEVERY SYSTEMOCULAR DRUG DELIEVERY SYSTEM
OCULAR DRUG DELIEVERY SYSTEMRohitGrover58
 
Ocular drug delivery system
Ocular drug delivery systemOcular drug delivery system
Ocular drug delivery systemArifinurRahman
 
Occural Drug Delivery System : Introduction , intra ocular barrier
Occural Drug Delivery System : Introduction , intra ocular barrierOccural Drug Delivery System : Introduction , intra ocular barrier
Occural Drug Delivery System : Introduction , intra ocular barrierRiyaDas765755
 
Ophthalmic drug delivery system
Ophthalmic drug delivery systemOphthalmic drug delivery system
Ophthalmic drug delivery systemBINDIYA PATEL
 
Occular Drug Delivary system (ODDS)
Occular Drug Delivary system (ODDS)Occular Drug Delivary system (ODDS)
Occular Drug Delivary system (ODDS)KavyasriPuttamreddy
 

Ähnlich wie oclar.pptx (20)

Barrier of drugs permeation through ocular route by Sushil Kumar Singh
Barrier of drugs permeation through ocular route by Sushil Kumar SinghBarrier of drugs permeation through ocular route by Sushil Kumar Singh
Barrier of drugs permeation through ocular route by Sushil Kumar Singh
 
Telithromycin ocular ointment
Telithromycin ocular ointmentTelithromycin ocular ointment
Telithromycin ocular ointment
 
ODDS(Jeevitha.KB).pptx
ODDS(Jeevitha.KB).pptxODDS(Jeevitha.KB).pptx
ODDS(Jeevitha.KB).pptx
 
Ssssssspofvv converted
Ssssssspofvv convertedSsssssspofvv converted
Ssssssspofvv converted
 
BARRIERS OF DRUG PERMEATION OF OCCULAR DRUG DELIVERY SYSTEM
BARRIERS OF DRUG PERMEATION OF OCCULAR DRUG DELIVERY SYSTEMBARRIERS OF DRUG PERMEATION OF OCCULAR DRUG DELIVERY SYSTEM
BARRIERS OF DRUG PERMEATION OF OCCULAR DRUG DELIVERY SYSTEM
 
Ophthalmic drugdelivery system
Ophthalmic drugdelivery systemOphthalmic drugdelivery system
Ophthalmic drugdelivery system
 
Ocular Drug Delivery System
Ocular Drug Delivery SystemOcular Drug Delivery System
Ocular Drug Delivery System
 
Barriers and routes of occular drug delivery system
Barriers and routes of occular drug delivery systemBarriers and routes of occular drug delivery system
Barriers and routes of occular drug delivery system
 
Occular Drug Delivery System
Occular Drug Delivery SystemOccular Drug Delivery System
Occular Drug Delivery System
 
Odds
OddsOdds
Odds
 
Odds ocular drug delivery system
Odds ocular drug delivery system Odds ocular drug delivery system
Odds ocular drug delivery system
 
OCULAR DRUG DELIEVERY SYSTEM
OCULAR DRUG DELIEVERY SYSTEMOCULAR DRUG DELIEVERY SYSTEM
OCULAR DRUG DELIEVERY SYSTEM
 
OCCULAR DRUG DELIVERY SYSTEM
OCCULAR DRUG DELIVERY SYSTEMOCCULAR DRUG DELIVERY SYSTEM
OCCULAR DRUG DELIVERY SYSTEM
 
Dds presentation
Dds presentationDds presentation
Dds presentation
 
Ocular drug delivery system
Ocular drug delivery systemOcular drug delivery system
Ocular drug delivery system
 
Ocular dds
Ocular ddsOcular dds
Ocular dds
 
Occural Drug Delivery System : Introduction , intra ocular barrier
Occural Drug Delivery System : Introduction , intra ocular barrierOccural Drug Delivery System : Introduction , intra ocular barrier
Occural Drug Delivery System : Introduction , intra ocular barrier
 
Ophthalmic drug delivery system
Ophthalmic drug delivery systemOphthalmic drug delivery system
Ophthalmic drug delivery system
 
Ocdds upp
Ocdds uppOcdds upp
Ocdds upp
 
Occular Drug Delivary system (ODDS)
Occular Drug Delivary system (ODDS)Occular Drug Delivary system (ODDS)
Occular Drug Delivary system (ODDS)
 

Mehr von SailajaReddyGunnam

Mehr von SailajaReddyGunnam (15)

Role and importance of asceptic area for microorganisms transferASEPTIC AREA ...
Role and importance of asceptic area for microorganisms transferASEPTIC AREA ...Role and importance of asceptic area for microorganisms transferASEPTIC AREA ...
Role and importance of asceptic area for microorganisms transferASEPTIC AREA ...
 
U-4 Tablet Compression Physics.pptx
U-4 Tablet Compression Physics.pptxU-4 Tablet Compression Physics.pptx
U-4 Tablet Compression Physics.pptx
 
polymers.pptx
polymers.pptxpolymers.pptx
polymers.pptx
 
staistical analysis ppt of CADD.pptx
staistical analysis ppt of CADD.pptxstaistical analysis ppt of CADD.pptx
staistical analysis ppt of CADD.pptx
 
distribution of drugs
distribution of drugsdistribution of drugs
distribution of drugs
 
Intrauterine Devices (IUDs).pptx
Intrauterine Devices (IUDs).pptxIntrauterine Devices (IUDs).pptx
Intrauterine Devices (IUDs).pptx
 
targetting(1).ppt
targetting(1).ppttargetting(1).ppt
targetting(1).ppt
 
Sterilization.pptx
Sterilization.pptxSterilization.pptx
Sterilization.pptx
 
mono clonals.pptx
mono clonals.pptxmono clonals.pptx
mono clonals.pptx
 
microencapsulation-ppt(1).pptx
microencapsulation-ppt(1).pptxmicroencapsulation-ppt(1).pptx
microencapsulation-ppt(1).pptx
 
culture media.pptx
culture media.pptxculture media.pptx
culture media.pptx
 
scope and history of microbiology.ppt
scope and history of microbiology.pptscope and history of microbiology.ppt
scope and history of microbiology.ppt
 
CRDDS introduction.pptx
CRDDS introduction.pptxCRDDS introduction.pptx
CRDDS introduction.pptx
 
Factors-affecting-tdds.pdf
Factors-affecting-tdds.pdfFactors-affecting-tdds.pdf
Factors-affecting-tdds.pdf
 
TRANSDERMAL DRUG DELIVERY SYSTEM.pptx
TRANSDERMAL DRUG DELIVERY SYSTEM.pptxTRANSDERMAL DRUG DELIVERY SYSTEM.pptx
TRANSDERMAL DRUG DELIVERY SYSTEM.pptx
 

Kürzlich hochgeladen

RCPE terms and cycles scenarios as of March 2024
RCPE terms and cycles scenarios as of March 2024RCPE terms and cycles scenarios as of March 2024
RCPE terms and cycles scenarios as of March 2024suelcarter1
 
Contracts with Interdependent Preferences (2)
Contracts with Interdependent Preferences (2)Contracts with Interdependent Preferences (2)
Contracts with Interdependent Preferences (2)GRAPE
 
Pests of wheat_Identification, Bionomics, Damage symptoms, IPM_Dr.UPR.pdf
Pests of wheat_Identification, Bionomics, Damage symptoms, IPM_Dr.UPR.pdfPests of wheat_Identification, Bionomics, Damage symptoms, IPM_Dr.UPR.pdf
Pests of wheat_Identification, Bionomics, Damage symptoms, IPM_Dr.UPR.pdfPirithiRaju
 
Exploration Method’s in Archaeological Studies & Research
Exploration Method’s in Archaeological Studies & ResearchExploration Method’s in Archaeological Studies & Research
Exploration Method’s in Archaeological Studies & ResearchPrachya Adhyayan
 
Human brain.. It's parts and function.
Human brain.. It's parts and function. Human brain.. It's parts and function.
Human brain.. It's parts and function. MUKTA MANJARI SAHOO
 
Pests of Redgram_Identification, Binomics_Dr.UPR
Pests of Redgram_Identification, Binomics_Dr.UPRPests of Redgram_Identification, Binomics_Dr.UPR
Pests of Redgram_Identification, Binomics_Dr.UPRPirithiRaju
 
MARSILEA notes in detail for II year Botany.ppt
MARSILEA  notes in detail for II year Botany.pptMARSILEA  notes in detail for II year Botany.ppt
MARSILEA notes in detail for II year Botany.pptaigil2
 
SUKDANAN DIAGNOSTIC TEST IN PHYSICAL SCIENCE ANSWER KEYY.pdf
SUKDANAN DIAGNOSTIC TEST IN PHYSICAL SCIENCE ANSWER KEYY.pdfSUKDANAN DIAGNOSTIC TEST IN PHYSICAL SCIENCE ANSWER KEYY.pdf
SUKDANAN DIAGNOSTIC TEST IN PHYSICAL SCIENCE ANSWER KEYY.pdfsantiagojoderickdoma
 
Krishi Vigyan Kendras - कृषि विज्ञान केंद्र
Krishi Vigyan Kendras - कृषि विज्ञान केंद्रKrishi Vigyan Kendras - कृषि विज्ञान केंद्र
Krishi Vigyan Kendras - कृषि विज्ञान केंद्रKrashi Coaching
 
Pests of cumbu_Identification, Binomics, Integrated ManagementDr.UPR.pdf
Pests of cumbu_Identification, Binomics, Integrated ManagementDr.UPR.pdfPests of cumbu_Identification, Binomics, Integrated ManagementDr.UPR.pdf
Pests of cumbu_Identification, Binomics, Integrated ManagementDr.UPR.pdfPirithiRaju
 
TORSION IN GASTROPODS- Anatomical event (Zoology)
TORSION IN GASTROPODS- Anatomical event (Zoology)TORSION IN GASTROPODS- Anatomical event (Zoology)
TORSION IN GASTROPODS- Anatomical event (Zoology)chatterjeesoumili50
 
KeyBio pipeline for bioinformatics and data science
KeyBio pipeline for bioinformatics and data scienceKeyBio pipeline for bioinformatics and data science
KeyBio pipeline for bioinformatics and data scienceLayne Sadler
 
Applied Biochemistry feedback_M Ahwad 2023.docx
Applied Biochemistry feedback_M Ahwad 2023.docxApplied Biochemistry feedback_M Ahwad 2023.docx
Applied Biochemistry feedback_M Ahwad 2023.docxmarwaahmad357
 
3.2 Pests of Sorghum_Identification, Symptoms and nature of damage, Binomics,...
3.2 Pests of Sorghum_Identification, Symptoms and nature of damage, Binomics,...3.2 Pests of Sorghum_Identification, Symptoms and nature of damage, Binomics,...
3.2 Pests of Sorghum_Identification, Symptoms and nature of damage, Binomics,...PirithiRaju
 
IB Biology New syllabus B3.2 Transport.pptx
IB Biology New syllabus B3.2 Transport.pptxIB Biology New syllabus B3.2 Transport.pptx
IB Biology New syllabus B3.2 Transport.pptxUalikhanKalkhojayev1
 
Pests of tenai_Identification,Binomics_Dr.UPR
Pests of tenai_Identification,Binomics_Dr.UPRPests of tenai_Identification,Binomics_Dr.UPR
Pests of tenai_Identification,Binomics_Dr.UPRPirithiRaju
 
Q3W4part1-SSSSSSSSSSSSSSSSSSSSSSSSCI.pptx
Q3W4part1-SSSSSSSSSSSSSSSSSSSSSSSSCI.pptxQ3W4part1-SSSSSSSSSSSSSSSSSSSSSSSSCI.pptx
Q3W4part1-SSSSSSSSSSSSSSSSSSSSSSSSCI.pptxArdeniel
 
Alternative system of medicine herbal drug technology syllabus
Alternative system of medicine herbal drug technology syllabusAlternative system of medicine herbal drug technology syllabus
Alternative system of medicine herbal drug technology syllabusPradnya Wadekar
 

Kürzlich hochgeladen (20)

RCPE terms and cycles scenarios as of March 2024
RCPE terms and cycles scenarios as of March 2024RCPE terms and cycles scenarios as of March 2024
RCPE terms and cycles scenarios as of March 2024
 
Contracts with Interdependent Preferences (2)
Contracts with Interdependent Preferences (2)Contracts with Interdependent Preferences (2)
Contracts with Interdependent Preferences (2)
 
Pests of wheat_Identification, Bionomics, Damage symptoms, IPM_Dr.UPR.pdf
Pests of wheat_Identification, Bionomics, Damage symptoms, IPM_Dr.UPR.pdfPests of wheat_Identification, Bionomics, Damage symptoms, IPM_Dr.UPR.pdf
Pests of wheat_Identification, Bionomics, Damage symptoms, IPM_Dr.UPR.pdf
 
Data delivery from the US-EPA Center for Computational Toxicology and Exposur...
Data delivery from the US-EPA Center for Computational Toxicology and Exposur...Data delivery from the US-EPA Center for Computational Toxicology and Exposur...
Data delivery from the US-EPA Center for Computational Toxicology and Exposur...
 
Cheminformatics tools and chemistry data underpinning mass spectrometry analy...
Cheminformatics tools and chemistry data underpinning mass spectrometry analy...Cheminformatics tools and chemistry data underpinning mass spectrometry analy...
Cheminformatics tools and chemistry data underpinning mass spectrometry analy...
 
Exploration Method’s in Archaeological Studies & Research
Exploration Method’s in Archaeological Studies & ResearchExploration Method’s in Archaeological Studies & Research
Exploration Method’s in Archaeological Studies & Research
 
Human brain.. It's parts and function.
Human brain.. It's parts and function. Human brain.. It's parts and function.
Human brain.. It's parts and function.
 
Pests of Redgram_Identification, Binomics_Dr.UPR
Pests of Redgram_Identification, Binomics_Dr.UPRPests of Redgram_Identification, Binomics_Dr.UPR
Pests of Redgram_Identification, Binomics_Dr.UPR
 
MARSILEA notes in detail for II year Botany.ppt
MARSILEA  notes in detail for II year Botany.pptMARSILEA  notes in detail for II year Botany.ppt
MARSILEA notes in detail for II year Botany.ppt
 
SUKDANAN DIAGNOSTIC TEST IN PHYSICAL SCIENCE ANSWER KEYY.pdf
SUKDANAN DIAGNOSTIC TEST IN PHYSICAL SCIENCE ANSWER KEYY.pdfSUKDANAN DIAGNOSTIC TEST IN PHYSICAL SCIENCE ANSWER KEYY.pdf
SUKDANAN DIAGNOSTIC TEST IN PHYSICAL SCIENCE ANSWER KEYY.pdf
 
Krishi Vigyan Kendras - कृषि विज्ञान केंद्र
Krishi Vigyan Kendras - कृषि विज्ञान केंद्रKrishi Vigyan Kendras - कृषि विज्ञान केंद्र
Krishi Vigyan Kendras - कृषि विज्ञान केंद्र
 
Pests of cumbu_Identification, Binomics, Integrated ManagementDr.UPR.pdf
Pests of cumbu_Identification, Binomics, Integrated ManagementDr.UPR.pdfPests of cumbu_Identification, Binomics, Integrated ManagementDr.UPR.pdf
Pests of cumbu_Identification, Binomics, Integrated ManagementDr.UPR.pdf
 
TORSION IN GASTROPODS- Anatomical event (Zoology)
TORSION IN GASTROPODS- Anatomical event (Zoology)TORSION IN GASTROPODS- Anatomical event (Zoology)
TORSION IN GASTROPODS- Anatomical event (Zoology)
 
KeyBio pipeline for bioinformatics and data science
KeyBio pipeline for bioinformatics and data scienceKeyBio pipeline for bioinformatics and data science
KeyBio pipeline for bioinformatics and data science
 
Applied Biochemistry feedback_M Ahwad 2023.docx
Applied Biochemistry feedback_M Ahwad 2023.docxApplied Biochemistry feedback_M Ahwad 2023.docx
Applied Biochemistry feedback_M Ahwad 2023.docx
 
3.2 Pests of Sorghum_Identification, Symptoms and nature of damage, Binomics,...
3.2 Pests of Sorghum_Identification, Symptoms and nature of damage, Binomics,...3.2 Pests of Sorghum_Identification, Symptoms and nature of damage, Binomics,...
3.2 Pests of Sorghum_Identification, Symptoms and nature of damage, Binomics,...
 
IB Biology New syllabus B3.2 Transport.pptx
IB Biology New syllabus B3.2 Transport.pptxIB Biology New syllabus B3.2 Transport.pptx
IB Biology New syllabus B3.2 Transport.pptx
 
Pests of tenai_Identification,Binomics_Dr.UPR
Pests of tenai_Identification,Binomics_Dr.UPRPests of tenai_Identification,Binomics_Dr.UPR
Pests of tenai_Identification,Binomics_Dr.UPR
 
Q3W4part1-SSSSSSSSSSSSSSSSSSSSSSSSCI.pptx
Q3W4part1-SSSSSSSSSSSSSSSSSSSSSSSSCI.pptxQ3W4part1-SSSSSSSSSSSSSSSSSSSSSSSSCI.pptx
Q3W4part1-SSSSSSSSSSSSSSSSSSSSSSSSCI.pptx
 
Alternative system of medicine herbal drug technology syllabus
Alternative system of medicine herbal drug technology syllabusAlternative system of medicine herbal drug technology syllabus
Alternative system of medicine herbal drug technology syllabus
 

oclar.pptx

  • 3. • The novel approach of drug delivery in which the drug is instilled on the cul de sac cavity of the eye (space between eyelids and eyeballs) is known as Ocular Drug Delivery System.
  • 4. • INTRODUCTION • Ocular administration of drug is primarily associated with the need to treat ophthalmic diseases. • Eye is the most easily accessible site for topical administration of a medication. • Ideal ophthalmic drug delivery must be able to sustain the drug release and to remain in the vicinity of front of the eye for prolong period of time.
  • 5. The eye is a complex organ with unique anatomy and physiology. The structure of the eye can be divided into two main parts: the anterior segment and the posterior segment. The anterior segment of the eye occupies approximately one-third while the remaining portion is occupied by the posterior segment. Tissues such as the cornea, conjunctiva, aqueous humor, iris, ciliary body, and lens make up the anterior portion. Back of the eye or posterior segment of the eye include; sclera, choroid, retinal pigment epithelium, neural retina, optic nerve, and vitreous humor.
  • 6. • The anterior and posterior segment of the eye is affected by various vision-threatening diseases. • glaucoma, allergic conjunctivitis, anterior uveitis, and cataract. • Age-related macular degeneration (AMD) and diabetic retinopathy
  • 8. Nasolachrymal drainage system Nasolachrymal drainage system consists of three parts; the secretory system, the distributive system and the excretory system. The secretory portion is composed of the lacrimal gland that secreted tears are spread over the ocular surface by the eyelids during blinking. The secretory system is stimulated by blinking and temperature change due to the tear evaporation and reflux secretors that have an efferent parasympathetic nerve supply and secrete in response to physical and emotional stimulation e.g. crying.
  • 9. The distributive system consists of the eyelids and the tear meniscus around the lid edges of the open eye, which spread tears over the ocular surface by blinking, thus preventing dry areas from developing. The excretory part of the Nasolachrymal drainage system consists of the lachrymal puncta, the superior, inferior and common canaliculi; the lachrymal sac, and the nasochrymal duct. In humans, the two puncta are the openings of the lachrymal canaliculi and are situated on an elevated area known as the lachrymal papilla. It is thought that tears are largely absorbed by the mucous membrane that lines the ducts andthe lachrymal sac; only a small amount reaches the nasal passage
  • 10. Tearfilm The exposed part of the eye is covered by a thin fluid layer, the so- called precorneal tear film. The film thickness is reported to be about 3–10 Am depending on the measurement method used. The resident volume amounts to about 10μl. The osmolality of the tear film equals 310–350 mOsm/kg in normal eyes and is adjusted by the monovalent and divalent inorganic ions such as Na+, K+, Cl-, HCO3-, and proteins. The mean pH value of normal tears is about 7.4.
  • 11. Advantages of Ocular Drug Delivery System • 1. Increased accurate dosing. To overcome the side effects of pulsed dosing produced by conventional systems. 2. To provide sustained and controlled drug delivery. 3. To increase the ocular bioavailability of drug by increasing the corneal contact time. This can be achieved by effective adherence to corneal surface. 4. To provide targeting within the ocular globe so as to prevent the loss to other ocular tissues. 5. To circumvent the protective barriers like drainage, lacrimation and conjunctival absorption.
  • 12. Disadvantages of Ocular Drug Delivery System • The residence time of the drug at the eye surface is less. • Poor bioavailability. • The instability of the dissolved drug. • The low concentration of preservatives reduces shelf life after opening the bottle.
  • 13. Ideal Characteristics of Ocular Drug Delivery System • It should be sterile. • It should be isotonic to body fluids. • Buffer/pH adjustment. • Less drainage tendency. • Minimum protein binding.
  • 14. • Mechanism of Ocular Drug Absorption • Drugs administered by instillation must penetrate the eye and do so primarily through the cornea followed by the non-corneal routes.These non-corneal routes involve drug diffusion across the conjunctiva and sclera and appear to be particularly important for drugs that are poorly absorbed across the cornea
  • 15. • Corneal permeation • The permeation of drugs across the corneal membrane occurs from the precorneal space. Transcellular transport occurs i.e. transport between corneal epithelium and stroma. • The productive absorption of most ophthalmic drugs results from diffusional process across corneal membrane. • Maximum absorption thus takes place through cornea, which leads the drug into aqueous humor. • Outer epithelium has only access to small ionic and lipophilic molecules.
  • 16. • Non-corneal permeation • Primary mechanism of drug permeation is diffusion across sclera & conjunctiva into intra ocular tissues. • Although like cornea, the conjunctiva is composed of an epithelial layer covering an underlying stroma, the conjunctival epithelium offers substantially less resistance than does the corneal epithelium. • This route is however, not productive as it restrains the entry of drug into aqueous humor. • This route is important for hydrophilic and large molecules, such as insulin and p-aminoclonidine, which have poor corneal permeability.
  • 17. Barriers to Ocular Drug Delivery System • When a dosage form is either administered topically or systemically, it faces multiple obstacles before it reaches its site of action. • As a result, ocular bioavailability from topically administered drugs is usually only 1%-7% of the applied dose.
  • 18. Drug loss from the ocular surface After instillation, the flow of lacrimal fluid removes instilled compounds from the surface of eye. Even though the lacrimal turnover rate is only about 1 µl/min the excess volume of the instilled fluid is flown to the nasolacrimal duct rapidly in a couple of minutes. Another source of non-productive drug removal is its systemic absorption instead of ocular absorption. Systemic absorption may take place either directly from the conjunctival sac via local blood capillaries or after the solution flow to the nasal cavity.
  • 19. • Lacrimal fluid-eye barriers Corneal epithelium limits drug absorption from the lacrimal fluid into the eye. The corneal epithelial cells form tight junctions that limit the paracellular drug permeation. • Therefore, lipophilic drugs have typically at least an order of magnitude higher permeability in the cornea than the hydrophilic drugs. In general, the conjunctiva is leakier epithelium than the cornea and its surface area is also nearly 20 times greater than that of the cornea
  • 20. Blood-ocular barriers The eye is protected from the xenobiotics in the blood stream by blood-ocular barriers. These barriers have two parts: blood-aqueous barrier and blood-retina barrier. The anterior blood-eye barrier is composed of the endothelial cells in the uveam (The middle layer of the eye beneath the sclera. It consists of the iris, ciliary body, and choroid). This barrier prevents the access of plasma albumin into the aqueous humor, and also limits the access of hydrophilic drugs from plasma into the aqueous humor. The posterior barrier between blood stream and eye is comprised of retinal pigment epithelium (RPE) and the tight walls of retinal capillaries. Unlike retinal capillaries the vasculature of the choroid has extensive blood flow and leaky walls. Drugs easily gain access to the choroidal extravascular space, but thereafter distribution into the retina is limited by the RPE and retinal endothelia.